Juno Therapeutics, Inc. v. Kite Pharma, Inc.
MEMORIAL SLOAN KETTERING CANCER CENTER, SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH and JUNO THERAPEUTICS, INC. |
KITE PHARMA, INC. |
20-1758 |
May 1, 2020 |
U.S. Court of Appeals, Federal Circuit |
Other |
Opinions
We have the following opinions for this case:
Description |
---|
Juno Therapeutics, Inc v. Kite Pharma, Inc. |
Docket Report
This docket was last retrieved on October 29, 2021. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 82 18 paper copies of Doc. No. [ # 81 ], received from Appellees Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research. [809440] [VDW] [Entered: 11/01/2021 02:27 PM] |
Filing 81 Petition for panel rehearing, for en banc rehearing filed by Appellees Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research. Service: 10/27/2021 by email. [808668] [20-1758] [Gregory Castanias] [Entered: 10/27/2021 10:01 PM] |
Filing 80 ORDER filed granting Appellees' motion [ # 79 ] to extend the time to file a petition for rehearing by 30 days, until 10/27/2021. No further extensions will be granted. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [799539] [MJL] [Entered: 09/15/2021 11:49 AM] |
Filing 79 MOTION of Appellees Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research to extend the time to file a Combined Petition for Panel Rehearing and Rehearing En Banc until 10/27/2021. Service: 09/14/2021 by email. [799200] [20-1758] [Gregory Castanias] [Entered: 09/14/2021 03:08 PM] |
Filing 78 NOTICE OF NON-COMPLIANCE: The submission of Juno Therapeutics, Inc. and Sloan Kettering Institute for Cancer Research, Motion [ # 77 ], is not in compliance with the rules of this court (see attached). Compliant document due 09/21/2021. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [799100] [MJL] [Entered: 09/14/2021 11:48 AM] |
Filing 77 MOTION of Appellees Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research to extend the time to file a Combined Petition for Panel Rehearing and Rehearing En Banc until 10/27/2021. Service: 09/14/2021 by email. [799074] [20-1758]. This motion is non-compliant. See Doc. No. [ # 78 ]. [Matthew Rubenstein] [Entered: 09/14/2021 10:59 AM] |
Filing 76 JUDGMENT. REVERSED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellee(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click # here . Service as of this date by the Clerk of Court. [795365] [MVH] [Entered: 08/26/2021 09:38 AM] |
Filing 75 OPINION filed for the court by Moore, Chief Judge; Prost, Circuit Judge and O'Malley, Circuit Judge. Precedential Opinion. Service as of this date by the Clerk of Court. [795364] [MVH] [Entered: 08/26/2021 09:37 AM] |
Filing 74 ORDER filed denying Appellees' motion [ # 73 ] for leave to file a letter brief. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [786795] [MJL] [Entered: 07/16/2021 01:53 PM] |
Filing 73 MOTION of Appellees Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research leave to file a supplemental brief. Service: 07/15/2021 by email. [786646] [20-1758] [Morgan Chu] [Entered: 07/15/2021 07:36 PM] |
Filing 72 NOTICE OF NON-COMPLIANCE: The submission of Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research, Letter [ # 71 ], is not in compliance with the rules of this court (see attached). Compliant document due 07/21/2021. Service as of this date by the Clerk of Court. [786241] [MJL] [Entered: 07/14/2021 03:32 PM] |
Filing 71 Letter from Appellees Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research Post-Argument Letter. Service: 07/13/2021 by email. [785999] [20-1758]. This document is non-compliant. See Doc. No. [ # 72 ]. [Morgan Chu] [Entered: 07/13/2021 08:18 PM] |
Filing 70 Submitted after ORAL ARGUMENT to Panel: Moore, Chief Judge; Prost, Circuit Judge and O'Malley, Circuit Judge. Arguing counsel: Mr. E. Joshua Rosenkranz for Kite Pharma, Inc. and Morgan Chu for Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research. Oral Argument Audio available # here . [784289] [JCP] [Entered: 07/06/2021 02:09 PM] |
Filing 69 Certification of Compliance with Protocols for In-Person Argument for Appellees Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research. Service: 06/29/2021 by email. [783350] [20-1758] [Morgan Chu] [Entered: 06/29/2021 07:37 PM] |
Filing 68 Certification of Compliance with Protocols for In-Person Argument for Appellant Kite Pharma, Inc.. Service: 06/29/2021 by email. [783245] [20-1758] [E. Rosenkranz] [Entered: 06/29/2021 02:23 PM] |
Filing 67 Response to notice of oral argument from Appellees Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research. Service: 06/24/2021 by email. [782558] [20-1758] [Morgan Chu] [Entered: 06/24/2021 04:46 PM] |
Filing 66 NOTICE OF NON-COMPLIANCE: The submission of Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research, Response to Notice of Oral Argument [ # 64 ], is not in compliance with the rules of this court (see attached). Compliant document due 07/01/2021. Service as of this date by the Clerk of Court. [782543] [MJL] [Entered: 06/24/2021 04:19 PM] |
Filing 65 ORDER filed. The 07/06/2021 oral argument will now be conducted in person in Courtroom 201 (see order for further details and requirements). By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [781707] [MJL] [Entered: 06/22/2021 12:40 PM] |
Filing 64 Response to notice of oral argument from Appellees Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research. Service: 06/15/2021 by email. [780403] [20-1758]. This document is non-compliant. See Doc. No. [ # 66 ]. [Elizabeth Tuan] [Entered: 06/15/2021 02:05 PM] |
Filing 63 Response to notice of oral argument from Appellant Kite Pharma, Inc.. Service: 06/15/2021 by email. [780379] [20-1758] [E. Rosenkranz] [Entered: 06/15/2021 01:14 PM] |
Filing 62 NOTICE OF TELEPHONIC ORAL ARGUMENT. Panel: 2107B. Case scheduled July 6, 2021. Response to Notice of Oral Argument due: 06/15/2021. Please review the attached Notice. The response to notice of oral argument form can be found # here . The Oral Argument Guide can be found # here . The Counsel Telephonic Argument Orientation Information can be found # here . Service as of this date by the Clerk of Court. [776523] [MJL] [Entered: 05/21/2021 04:06 PM] |
Filing 61 ORDER filed granting motion to reschedule argument [ # 59 ] filed by Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [766476] [MJL] [Entered: 04/02/2021 01:55 PM] |
Filing 60 REPLY of Appellant Kite Pharma, Inc. to response [ # 56 ]. Service: 03/26/2021 by email. [765119] [20-1758] [E. Rosenkranz] [Entered: 03/26/2021 02:57 PM] |
Filing 59 MOTION of Appellees Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research to reschedule argument. Service: 03/25/2021 by email. [764780] [20-1758] [Elizabeth Tuan] [Entered: 03/25/2021 03:37 PM] |
Filing 58 NOTICE OF TELEPHONIC ORAL ARGUMENT. Panel: 2105A. Case scheduled May 3, 2021. Response to Notice of Oral Argument due: 04/15/2021. The Clerk's Office will provide additional instructions to counsel at least one week ahead of argument. Please review the attached Notice. The response to notice of oral argument form can be found # here . The Oral Argument Guide can be found # here . Service as of this date by the Clerk of Court. [763953] [MJL] [Entered: 03/22/2021 05:20 PM] |
Filing 57 Notice from Appellant Kite Pharma, Inc. to Withdraw as Counsel. Service: 03/17/2021 by email. [762910] [20-1758] [Grant Rice] [Entered: 03/17/2021 11:00 AM] |
Filing 56 RESPONSE of Appellees Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research to Doc No. [ # 47 ]. Service: 03/16/2021 by email. [762783] [20-1758] [Jennifer Swize] [Entered: 03/16/2021 06:17 PM] |
Filing 55 The following conflict dates submitted by E. Joshua Rosenkranz for Kite Pharma, Inc. have been accepted by the court: 06/10/2021, 06/11/2021. [760478] [MJL] [Entered: 03/05/2021 04:20 PM] |
Filing 54 The following conflict dates submitted by Morgan Chu for Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research have been accepted by the court: 06/07/2021, 06/08/2021, 06/09/2021, 06/10/2021, 06/11/2021, 10/04/2021, 10/05/2021, 10/06/2021, 10/07/2021, 10/08/2021. [760473] [MJL] [Entered: 03/05/2021 04:14 PM] |
Filing 52 Notice from Appellant Kite Pharma, Inc. regarding conflicts with oral argument. Service: 03/03/2021 by email. [759924] [20-1758] [E. Rosenkranz] [Entered: 03/03/2021 07:55 PM] |
Filing 51 Notice from Appellees Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research regarding conflicts with oral argument. Service: 03/03/2021 by email. [759898] [20-1758] [Elizabeth Tuan] [Entered: 03/03/2021 04:49 PM] |
Filing 53 6 paper copies of Doc. No. [ # 36 ] received from Appellees Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research. [760300] [VDW] [Entered: 03/05/2021 11:08 AM] |
Filing 50 6 paper copies of Doc. No. [32], [ # 41 ], [44] received from Appellant Kite Pharma, Inc.. [759394] [VDW] [Entered: 03/02/2021 09:18 AM] |
Filing 49 Notice to counsel: The Clerk's Office directs that outstanding paper copies of all briefs and appendices in this case must be submitted on or before March 3, 2021. See Administrative Order No. 20-01 (Mar. 20, 2020).[758182] [KMH] [Entered: 02/24/2021 09:37 AM] |
Filing 48 Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found # here . The Oral Argument Guide can be found # here . [758180] [KMH] [Entered: 02/24/2021 09:35 AM] |
Filing 47 Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellant Kite Pharma, Inc.. Service: 02/22/2021 by email. [757729] [20-1758] [E. Rosenkranz] [Entered: 02/22/2021 04:29 PM] |
Filing 46 Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellees Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research. Service: 02/16/2021 by email. [756412] [20-1758] [Matthew Rubenstein] [Entered: 02/16/2021 03:46 PM] |
Filing 45 Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellant Kite Pharma, Inc.. Service: 02/16/2021 by email. [756337] [20-1758] [E. Rosenkranz] [Entered: 02/16/2021 02:54 PM] |
Filing 44 MODIFIED ENTRY: CONFIDENTIAL APPENDIX FILED by Appellant Kite Pharma, Inc.. Service: 02/16/2021 by email. [756333]--[Edited 02/24/2021 by KMH - compliance review complete] [E. Rosenkranz] [Entered: 02/16/2021 02:46 PM] |
Filing 43 MODIFIED ENTRY: APPENDIX FILED by Appellant Kite Pharma, Inc.. Service: 02/16/2021 by email. [756326] --[Edited 02/24/2021 by KMH - compliance review complete] [E. Rosenkranz] [Entered: 02/16/2021 02:40 PM] |
Filing 42 Joint Statement of Compliance with Fed. Cir. R. 33 for Appellees Juno Therapeutics, Inc., Sloan Kettering Institute For Cancer Research and Appellant Kite Pharma, Inc.. Service: 02/16/2021 by email. [756306] [20-1758] [E. Rosenkranz] [Entered: 02/16/2021 02:10 PM] |
Filing 41 MODIFIED ENTRY: REPLY BRIEF FILED by Appellant Kite Pharma, Inc.. Service: 02/08/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [754572] --[Edited 02/10/2021 by KMH - compliance review complete] [E. Rosenkranz] [Entered: 02/08/2021 04:00 PM] |
Filing 40 ORDER granting motion to extend time to file brief [ # 39 ]. The reply brief is due 02/08/2021. Service as of this date by the Clerk of Court. [746220] [NL] [Entered: 12/31/2020 11:17 AM] |
Filing 39 MOTION of Appellant Kite Pharma, Inc. to extend the time to 02/08/2021 to file brief. Service: 12/23/2020 by email. [745148] [20-1758] [E. Rosenkranz] [Entered: 12/23/2020 03:13 PM] |
Filing 38 NOTICE OF NON-COMPLIANCE: The submission of , Motion for Extension of Time [ # 37 ], is not in compliance with the rules of this court (see attached). Compliant document due on 01/04/2021. Service as of this date by the Clerk of Court. [745070] [CAB] [Entered: 12/23/2020 12:30 PM] |
Filing 37 MOTION of Appellant Kite Pharma, Inc. to extend the time to 02/08/2021 to file brief. Service: 12/22/2020 by email. [744844] [20-1758] This document is non-compliant. See Doc No. [ # 38 ] [E. Rosenkranz] [Entered: 12/22/2020 03:56 PM] |
Filing 36 MODIFIED ENTRY: BRIEF FILED by Appellees Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research. Service: 12/14/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [742652] --[Edited 01/08/2021 by KMH - compliance review complete] [Lisa Furby] [Entered: 12/14/2020 08:12 PM] |
Filing 35 **TEXT ONLY** ORDER granting motion to extend time to file brief [ # 34 ] filed by Appellees Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research. The response brief is due 12/14/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [726092] [LMN] [Entered: 10/02/2020 10:52 AM] |
Filing 34 MOTION of Appellees Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research to extend the time to 12/14/2020 to file brief.. Service: 10/01/2020 by email. [725959] [20-1758] [Matthew Rubenstein] [Entered: 10/01/2020 04:06 PM] |
Filing 33 Entry of appearance for Lisa L. Furby as counsel for Appellees Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research. Service: 10/01/2020 by email. [725949] [20-1758] [Lisa Furby] [Entered: 10/01/2020 03:49 PM] |
Filing 32 MODIFIED ENTRY: CONFIDENTIAL OPENING BRIEF FILED for Appellant Kite Pharma, Inc. Number of Pages: 80. Service: 08/31/2020 by email. [718660]--[Edited 09/01/2020 by LMN - compliance review complete] [E. Rosenkranz] [Entered: 08/31/2020 08:25 PM] |
Filing 31 MODIFIED ENTRY: OPENING BRIEF FILED for Appellant Kite Pharma, Inc. Number of Pages: 80. Service: 08/31/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [718656] --[Edited 09/01/2020 by LMN - compliance review complete] [E. Rosenkranz] [Entered: 08/31/2020 08:09 PM] |
Filing 30 **TEXT ONLY** ORDER granting motion to extend time to file brief [ # 29 ] filed by Appellant Kite Pharma, Inc. The opening brief is due 08/31/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [698806] [LMN] [Entered: 06/03/2020 09:16 AM] |
Filing 29 MOTION of Appellant Kite Pharma, Inc. to extend the time to 08/31/2020 to file the opening brief. [Consent: unopposed]. Service: 06/02/2020 by email. [698752] [20-1758] [E. Rosenkranz] [Entered: 06/02/2020 04:54 PM] |
Filing 28 Entry of appearance for Matthew J. Rubenstein as of counsel for Appellees Juno Therapeutics, Inc. and Sloan Kettering Institute For Cancer Research. Service: 05/28/2020 by email. [697492] [20-1758] [Matthew Rubenstein] [Entered: 05/28/2020 11:05 AM] |
Filing 27 Official caption revised to reflect the termination of Memorial Sloan Kettering Cancer Center. (see attached). Service as of this date by the Clerk of Court. [696118] [LMN] [Entered: 05/21/2020 10:07 AM] |
Filing 26 **TEXT ONLY** ORDER granting motion to modify the official caption [ # 25 ] filed by Appellees Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center and Sloan Kettering Institute For Cancer Research.; modifying the official caption. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [696116] [LMN] [Entered: 05/21/2020 10:06 AM] |
Filing 25 MOTION of Appellees Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center and Sloan Kettering Institute For Cancer Research to modify the official caption [Consent: unopposed]. Service: 05/20/2020 by email. [695912] [20-1758] [Jennifer Swize] [Entered: 05/20/2020 12:54 PM] |
Filing 24 Entry of appearance for Alan J. Heinrich as of counsel for Appellees Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center and Sloan Kettering Institute For Cancer Research. Service: 05/18/2020 by email. [695360] [20-1758] [Jennifer Swize] [Entered: 05/18/2020 02:24 PM] |
Filing 23 Entry of appearance for Morgan Chu as of counsel for Appellees Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center and Sloan Kettering Institute For Cancer Research. Service: 05/18/2020 by email. [695358] [20-1758] [Jennifer Swize] [Entered: 05/18/2020 02:22 PM] |
Filing 22 Entry of appearance for Elizabeth C. Tuan as of counsel for Appellees Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center and Sloan Kettering Institute For Cancer Research. Service: 05/18/2020 by email. [695357] [20-1758] [Jennifer Swize] [Entered: 05/18/2020 02:20 PM] |
Filing 21 REMINDER : Attorney Jeffries is reminded that the information on the Entry of Appearance (EOA) and the information in the user account must match. Please promptly update the EOA or the account information on www.pacer.gov. [695140] [LMN] [Entered: 05/18/2020 08:46 AM] |
Filing 20 Docketing Statement for the Appellees Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center and Sloan Kettering Institute For Cancer Research. Service: 05/15/2020 by email. [695069] [20-1758] [Jennifer Swize] [Entered: 05/15/2020 04:30 PM] |
Filing 19 Certificate of Interest for Appellees Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center and Sloan Kettering Institute For Cancer Research. Service: 05/15/2020 by email. [695068] [20-1758] [Jennifer Swize] [Entered: 05/15/2020 04:28 PM] |
Filing 18 Entry of appearance for Andrea W. Jeffries as of counsel for Appellees Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center and Sloan Kettering Institute For Cancer Research. Service: 05/15/2020 by email. [695067] [20-1758] [Jennifer Swize] [Entered: 05/15/2020 04:26 PM] |
Filing 17 Entry of appearance for Jennifer L. Swize as of counsel for Appellees Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center and Sloan Kettering Institute For Cancer Research. Service: 05/15/2020 by email. [695066] [20-1758] [Jennifer Swize] [Entered: 05/15/2020 04:23 PM] |
Filing 16 Entry of appearance for Gregory A. Castanias as principal counsel for Appellees Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center and Sloan Kettering Institute For Cancer Research. Service: 05/15/2020 by email. [695064] [20-1758] [Jennifer Swize] [Entered: 05/15/2020 04:20 PM] |
Filing 15 Entry of appearance for Geoffrey D. Biegler as of counsel for Appellant Kite Pharma, Inc.. Service: 05/14/2020 by email. [694626] [20-1758] [Geoffrey Biegler] [Entered: 05/14/2020 02:29 PM] |
Filing 14 Entry of appearance for Grant T. Rice as of counsel for Appellant Kite Pharma, Inc.. Service: 05/14/2020 by email. [694606] [20-1758] [Grant Rice] [Entered: 05/14/2020 01:51 PM] |
Filing 13 REMINDER : Attorney Vincent is reminded that the information on the Entry of Appearance (EOA) and the information in the user account must match. Please promptly update the EOA or the account information on www.pacer.gov. [694583] [LMN] [Entered: 05/14/2020 01:31 PM] |
Filing 12 Entry of appearance for Jeffrey I. Weinberger as of counsel for Appellant Kite Pharma, Inc.. Service: 05/14/2020 by email. [694519] [20-1758] [Adam Lawton] [Entered: 05/14/2020 11:55 AM] |
Filing 11 Entry of appearance for Garth T. Vincent as of counsel for Appellant Kite Pharma, Inc.. Service: 05/14/2020 by email. [694517] [20-1758] [Adam Lawton] [Entered: 05/14/2020 11:54 AM] |
Filing 10 Entry of appearance for Peter E. Gratzinger as of counsel for Appellant Kite Pharma, Inc.. Service: 05/14/2020 by email. [694516] [20-1758] [Adam Lawton] [Entered: 05/14/2020 11:53 AM] |
Filing 9 Entry of appearance for Ted Dane as of counsel for Appellant Kite Pharma, Inc.. Service: 05/14/2020 by email. [694514] [20-1758] [Adam Lawton] [Entered: 05/14/2020 11:51 AM] |
Filing 8 Entry of appearance for Adam R. Lawton as of counsel for Appellant Kite Pharma, Inc.. Service: 05/14/2020 by email. [694512] [20-1758] [Adam Lawton] [Entered: 05/14/2020 11:49 AM] |
Filing 7 Docketing Statement for the Appellant Kite Pharma, Inc.. Service: 05/11/2020 by email. [693636] [20-1758] [E. Rosenkranz] [Entered: 05/11/2020 04:33 PM] |
Filing 6 Certificate of Interest for Appellant Kite Pharma, Inc.. Service: 05/11/2020 by email. [693632] [20-1758] [E. Rosenkranz] [Entered: 05/11/2020 04:30 PM] |
Filing 5 Entry of appearance for Jeremy Peterman as of counsel for Appellant Kite Pharma, Inc.. Service: 05/04/2020 by email. [692100] [20-1758] [Jeremy Peterman] [Entered: 05/04/2020 05:34 PM] |
Filing 4 Entry of appearance for Robbie Manhas as of counsel for Appellant Kite Pharma, Inc.. Service: 05/04/2020 by email. [692098] [20-1758] [Robert Manhas] [Entered: 05/04/2020 05:31 PM] |
Filing 3 Entry of appearance for Melanie L. Bostwick as of counsel for Appellant Kite Pharma, Inc.. Service: 05/04/2020 by email. [692096] [20-1758] [Melanie Bostwick] [Entered: 05/04/2020 05:27 PM] |
Filing 2 Entry of appearance for E. Joshua Rosenkranz as principal counsel for Appellant Kite Pharma, Inc.. Service: 05/04/2020 by email. [692094] [20-1758] [E. Rosenkranz] [Entered: 05/04/2020 05:22 PM] |
Filing 1 Appeal docketed. Received: 04/23/2020. [691526] Entry of Appearance is due 05/15/2020. Certificate of Interest is due on 05/15/2020. Docketing Statement is due 05/15/2020. Appellant's brief is due 06/30/2020. [LMN] [Entered: 05/01/2020 09:24 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.